Search for Clinical Trial Results
Hereditary Angioedema - 34 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1 Esterase Inhibitor for the Prevention of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema Condition: Hereditary Angioedema (HAE) Date: 2015-10-20 Interventions: Drug: C1 esterase inhibitor [human] liquid C1 Esterase Inhibitor [Human] Liquid administered Subcutaneou |
Terminated |
Study Name: Open-label, Long-term Safety Study of Avoralstat in Subjects With Hereditary Angioedema Condition:
Date: 2016-01-20 Interventions: Drug: avoralstat Other Name: BCX4161 |
Completed |
Study Name: C1 Esterase Inhibitor in Hereditary Angioedema (HAE)(Extension Study) Condition: Hereditary Angioedema Date: 2006-02-15 Interventions: Drug: C1 Esterase Inhibitor Lyophilisate containing approximately 500 U C1-INH to be reconstituted with |
Completed |
Study Name: Human C1 Esterase Inhibitor (C1-INH) in Subjects With Acute Abdominal or Facial Hereditary Angioedema (HAE) Attacks Condition: Hereditary Angioedema Date: 2005-09-12 Interventions:
|
Completed |
Study Name: C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks Condition: Hereditary Angioedema Date: 2006-02-07 Interventions:
|
Active, not recruiting |
Study Name: A Study to Evaluate the Long-term Clinical Safety and Efficacy of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema Condition: Hereditary Angioedema Types I and II Date: 2014-12-10 Interventions: Biological: C1-esterase inhibitor |
Completed |
Study Name: A Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema Condition: Hereditary Angioedema Types I and II Date: 2013-07-29 Interventions:
|
Recruiting |
Study Name: Study to Assess the Tolerability and Safety of Ecallantide in Children and Adolescents With Hereditary Angioedema Condition: Hereditary Angioedema Types I and II Date: 2013-04-04 Interventions: Drug: Ecallantide subcutaneous dosing For acute attacks of Hereditary Angioedema in children and adolesc |
Completed |
Study Name: A Study to Evaluate the Safety and Pharmacokinetics of Two Formulations of C1-esterase Inhibitor Condition: Hereditary Angioedema Types I and II Date: 2012-12-24 Interventions:
|
Completed |
Study Name: A Study to Evaluate the Clinical Pharmacology and Safety of C1-esterase Inhibitor Administered by the Subcutaneous Route Condition: Hereditary Angioedema Types I and II Date: 2012-04-10 Interventions:
|